Prosecution Insights
Last updated: October 04, 2026
Application No. 18/547,751

PATIENT RESPONSE-BASED BIOMARKER TOPOLOGY QUANTIFICATION AND ASSESSMENT FOR MULTIPLE TISSUE TYPES

Non-Final OA §101
Filed
Aug 24, 2023
Priority
Feb 25, 2021 — continuation of 63/153,723 +1 more
Examiner
FITZPATRICK, ATIBA O
Art Unit
2677
Tech Center
2600 — Communications
Assignee
Bristol-Myers Squibb Company
OA Round
3 (Non-Final)
88%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 88% — above average
88%
Career Allowance Rate
799 granted / 913 resolved
+25.5% vs TC avg
Moderate +6% lift
Without
With
+6.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
18 currently pending
Career history
921
Total Applications
across all art units

Statute-Specific Performance

§101
16.4%
-23.6% vs TC avg
§103
35.6%
-4.4% vs TC avg
§102
21.0%
-19.0% vs TC avg
§112
19.3%
-20.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 913 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 07/17/2026 has been entered. Response to Amendments Claim amendments have not overcome the 35 USC 101 rejections. Response to Arguments Applicant's arguments pertaining to the 35 USC § 101 have been fully considered but they are not persuasive. On page 9 of Applicant’s remarks, Applicant argues that: PNG media_image1.png 631 1428 media_image1.png Greyscale Examiner agrees that limitations “performing image analysis [[ on ]]by applying an artificial neural network” are non-judicial exception additional elements that cannot be interpreted as being performed in the human mind. In the subsequent paragraph, Applicant argues that: PNG media_image2.png 485 1428 media_image2.png Greyscale Examiner respectfully disagrees. Firstly, the claim does not recite “pixel-level segmentation” or even “segmentation” or “counting” or “clinical classification”. Applicant’s characterizations, in these regards, are not commensurate with the claim scope, and so are moot points. Recall that claim limitations are given their broadest reasonable interpretation without reading limitations from the specification into the claims. However, even considering the original disclosure, the specification does not disclose “pixel-level segmentation” or an artificial neural network performing counting; thus, these limitations are not available for amending into the claims. Also note that the claim does not recite, “quantify”. However, the limitations “obtain image analysis results indicating CD8+ T-cell abundance in tumor parenchyma and stroma in the histology image” can be reasonably be interpreted as a human observer, such as a pathologist or topologist, viewing a displayed histology image and visually observing differential staining of the tumor stroma and parenchyma and mentally indicating CD8+ T-cell abundance via visual perception of CD8+ T-cell density present within the stroma and parenchyma. Note that the claim does not require an interpretation of counting, but a human can visually count individual cells present in a displayed image. Never-the-less, “abundance”, as claimed is a high-level metric that does not require an interpretation of counting. Also, note that even if the claim generically recited “segmentation”, which it does not, that pathologists often mentally perform segmentation of tumor stroma and parenchyma, via visual perception, by view displayed stained histology images. In the second paragraph on page 10 of Applicant’s remarks, Applicant argues that: PNG media_image3.png 422 1406 media_image3.png Greyscale Examiner agrees that these limitations cannot be interpreted as mental processes. However, these limitations are recited math abstract ideas. In the subsequent paragraph, Applicant argues that: PNG media_image4.png 801 1415 media_image4.png Greyscale Examiner respectfully disagrees. “Polar coordinate transformations” are explicitly recited mathematical operations. They are mathematical transformations that transform data from another coordinate space (e.g. cartesian coordinate space) to polar coordinates. This is a mathematical relationship and calculation. Applicant refers to Example 39, but “training a neural network” is not recited math. Example 39 is not analogous to Applicant’s claim 61. Example 39 does not recite any judicial exceptions. In the last paragraph on page 10 of Applicant’s remarks, Applicant argues that: PNG media_image5.png 353 1425 media_image5.png Greyscale Examiner respectfully disagrees. Claim 61 is comprised primarily of mental and recited math abstract ideas. The only non-judicial exception additional elements present in the claim are the computer component limitations, the insignificant extra-solution activity data gathering limitations, and the generically recited artificial neural network image analysis limitations. The limitations, “generating a recommendation for a treatment option”, themselves, can be reasonably interpreted as being mentally performed by a human observer, such as a pathologist, topologist, or physician, visually perceiving relevant plotted data in the feature coordinate space in conjunction with visually perceiving the lines through the coordinate space marking linear boundaries or linear cutoffs and mentally determining a suitable recommendation for a treatment option. The claims do not require an alternative interpretation and do not prohibit this interpretation. Note that judicial exceptions cannot incorporate judicial exceptions into a practical application or constitute significantly more than the judicial exceptions. Beginning atop page 11 of Applicant’s remarks, Applicant argues that: PNG media_image6.png 1004 1422 media_image6.png Greyscale Examiner respectfully disagrees. These excerpts indicate that humans can indeed perform these operations, which confirms the interpretation that the limitations “obtain image analysis results indicating CD8+ T-cell abundance in tumor parenchyma and stroma in the histology image” can be reasonably be interpreted as a human observer, such as a pathologist or topologist, viewing a displayed histology image and visually observing differential staining of the tumor stroma and parenchyma and mentally indicating CD8+ T-cell abundance via visual perception of CD8+ T-cell density present within the stroma and parenchyma. These excerpts explain why “performing image analysis by applying an artificial neural network” is an improvement on manual interpretation due to significant inter-reviewer variability. Thus, “performing image analysis by applying an artificial neural network to the histology image” is solving a problem but is recited at a high level of generality, i.e. generically recited, and thus cannot incorporate the mental process abstract idea of visual perception into a practical application. Also, “performing image analysis by applying an artificial neural network to the histology image” is well-understood, routine, conventional. These excerpts also state that the patient response model is an improvement or solution. However, the patient response model is recited math abstract idea judicial exception, and judicial exceptions cannot incorporate judicial exceptions into a practical application or constitute significantly more than the judicial exceptions. Subsequently, in the third and fourth paragraphs on page 11 of Applicant’s remarks, Applicant argues that: PNG media_image7.png 922 1428 media_image7.png Greyscale Examiner respectfully disagrees. Here, the Desjardin memo is referring to the additional elements or ordered combination of additional elements or the ordered combination of additional elements as affected by and affecting the judicial exceptions. The broadest reasonable interpretation of the claims was carefully ascertained prior to the subject matter eligibility analysis. The interpretations were carefully explained in the rejection below and response to arguments above. See the paragraphs above concerning improvements or solutions. On page 12 of Applicant’s remarks, Applicant argues that: PNG media_image8.png 982 1065 media_image8.png Greyscale Examiner respectfully disagrees. Let us carefully consider the referenced portion on page 4 of the August 4, 2025 Memo. The sentence here is, “An important consideration in determining whether a claim improves technology or a technical field is the extent to which the claim covers a particular solution to a problem or a particular way to achieve a desired outcome, as opposed to merely claiming the idea of a solution or outcome”. “performing image analysis by applying an artificial neural network to the histology image” is not a particular solution. These limitations are generically recited. Applicant refers to Claim 3 of Example 47. Let us carefully consider this example. Here is the synopsis for claims 1-3: PNG media_image9.png 451 1400 media_image9.png Greyscale Note that “Claim 2 is ineligible because it recites a judicial exception (abstract idea), and the claim as a whole does not integrate the exception into a practical application (and is thus directed to an abstract idea), and the claim does not provide significantly more than the exception (does not provide an inventive concept”. Here is that claim 2: PNG media_image10.png 618 1371 media_image10.png Greyscale Example 47’s Claim 2 better matches the fact patterns of Applicant’s claim 61 than Example 47’s claim 3. See that that detection and analysis of anomalies is performed using the ANN and results of this analysis are output. Page 6 of the July 2024 Subject Matter Eligibility Examples explains: PNG media_image11.png 568 1077 media_image11.png Greyscale Page 7 of the July 2024 Subject Matter Eligibility Examples explains: PNG media_image12.png 787 1075 media_image12.png Greyscale The last paragraph on page 8 to the fifth paragraph on page 9 of the July 2024 Subject Matter Eligibility Examples explains: PNG media_image13.png 1202 1078 media_image13.png Greyscale Page 10 of the July 2024 Subject Matter Eligibility Examples explains: PNG media_image14.png 221 1079 media_image14.png Greyscale Example 47 claim 2 matches the fact patterns of Applicant’s claim 61 because it involves performing detection and analysis using an ANN to perform actions disclosed as being mentally performed by humans. Analogous analysis is performed on claim 61. The key take away here is that, although an ANN is an additional element, it is a generic recitation for all the reasons provided above in the explanation of this example. Regarding claim 3 of Example 47, “detecting source addresses, dropping malicious packets, blocking future traffic” are not generically recited. Here are the limitations in question: PNG media_image15.png 253 1361 media_image15.png Greyscale These limitations are clearly additional elements that are not judicial exceptions such as mental process or recited math abstract ideas. Also, these limitations are particularly recited. This is not analogous to Applicant’s claim 61. Returning to our consideration of Ex Parte Desjardins, indeed Desjardins’ claims reflected improvements to how a machine learning model itself operate. Considering the December 5, 2025 MEMORANDUM Advance notice of change to the MPEP in light of Ex Parte Desjardins, page 2 of the memo states: PNG media_image16.png 662 1069 media_image16.png Greyscale See that the claim limitations “adjust the first values of the plurality of parameters to optimize performance of the machine learning model on the second machine learning task while protecting performance of the machine learning model on the first machine learning task” are clearly non-judicial exception additional elements that are not mental process or recited math abstract ideas that are particularly recited and constitute an improvement or solution. The analysis for these limitations is not analogous to that of Applicant’s claim 61. Also, returning to discussion of limitations “obtain image analysis results indicating CD8+ T-cell abundance in tumor parenchyma and stroma in the histology image” being reasonably interpretable as a human observer, such as a pathologist or topologist, viewing a displayed histology image and visually observing differential staining of the tumor stroma and parenchyma and mentally indicating CD8+ T-cell abundance via visual perception of CD8+ T-cell density present within the stroma and parenchyma, let us carefully consider Shimizu S, Hiratsuka H, Koike K, Tsuchihashi K, Sonoda T, Ogi K, Miyakawa A, Kobayashi J, Kaneko T, Igarashi T, Hasegawa T, Miyazaki A. Tumor-infiltrating CD8+ T-cell density is an independent prognostic marker for oral squamous cell carcinoma. Cancer Med. 2019 Jan;8(1):80-93. doi: 10.1002/cam4.1889. Epub 2019 Jan 1. PMID: 30600646; PMCID: PMC6346233 (Shimizu) provided by Applicant in information disclosure statement (IDS) filed 04/20/2026: PNG media_image17.png 839 1159 media_image17.png Greyscale Associated page 84 shows: PNG media_image18.png 1317 566 media_image18.png Greyscale These portions show that “obtain image analysis results indicating CD8+ T-cell abundance in tumor parenchyma and stroma in the histology image” can be mentally performed where cells are manually counted in determining density as abundance. These teachings of Shimizu are not necessary for the 35 USC 101 rejection, but are meant to be supplemental to further elucidate the point. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 61-70 and 73-82 are rejected under 35 U.S.C. 101 because the claimed invention is directed to recited math and mental process abstract ideas without significantly more. Claim(s) 61 recite(s): “method for identifying a subject suitable for immunotherapy to treat a tumor of the subject”, which can be reasonably interpreted as being mentally performed by a human observer considering relevant data. “obtain image analysis results indicating CD8+ T-cell abundance in tumor parenchyma and stroma in the histology image”, which can be reasonably be interpreted as a human observer, such as a pathologist or topologist, viewing a displayed histology image and visually observing differential staining of the tumor stroma and parenchyma and mentally indicating CD8+ T-cell abundance via visual perception of CD8+ T-cell density present within the stroma and parenchyma; “processing a polar coordinate transformation of the image analysis results indicating the CD8+ T-cell abundance in tumor parenchyma and stroma to determine: a real inflammation score of the sample of the tumor; and a tumor infiltration score of the sample of the tumor”, which is recited math of polar coordinate transformation of coordinates to calculate a real inflammation score and a tumor infiltration score; “determining, from a plurality of possible classifications of CD8 localization, a classification of CD8 localization in the sample of the tumor”, which can be reasonably interpreted as being mentally performed by a human observer visually perceiving relevant plotted data; “by applying a patient response model to the polar coordinate transformation of the image analysis results that maps a value of the real inflammation score and a value of the tumor infiltration score in a feature space, the feature space comprising a plot having a first axis and a second axis and defining linear boundaries or linear cutoffs between the plurality of possible classifications of CD8 localization, wherein the linear boundaries or linear cutoffs are identified by iteratively fitting boundary defining values for the real inflammation score and the tumor infiltration score in the feature space based on patient response data”, which is recited math of applying a mathematical model, such as regression, in transforming the result of the polar coordinate transformation into a feature coordinate space with axes of real inflammation and tumor infiltration and calculated lines through the coordinate space marking linear boundaries or linear cutoffs; and “generating a recommendation for a treatment option of the subject based on the classification of the CD8 localization in the sample of the tumor”, which can be reasonably interpreted as being mentally performed by a human observer visually perceiving relevant plotted data in the feature coordinate space in conjunction with visually perceiving the lines through the coordinate space marking linear boundaries or linear cutoffs. This judicial exception is not integrated into a practical application because additional elements of: “A computer-implemented method… the method executing on data processing hardware that causes the data processing hardware to perform operations comprising” are generically recited computer elements that do not add a meaningful limitation to the abstract idea because they amount to simply implementing the abstract idea on a computer; and “receiving a histology image of a sample of the tumor of the subject” are generically recited insignificant extra-solution activity of data gathering; “performing image analysis by applying an artificial neural network to the histology image to obtain image analysis results” are generically recited; “comprising retrospective clinical response data indicating whether or not each patient in a plurality of patients is responsive to a treatment or therapy” are generically recited insignificant extra-solution activity of data gathering; The claim(s) does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception because additional elements of: “A computer-implemented method… the method executing on data processing hardware that causes the data processing hardware to perform operations comprising” are mere instructions to implement an abstract idea on a computer, or merely uses a computer as a tool to perform an abstract idea - see MPEP 2106.05(f); “receiving a histology image of a sample of the tumor of the subject” are insignificant extra-solution activity of data gathering; “performing image analysis by applying an artificial neural network to the histology image to obtain image analysis results” are well understood, routine, conventional; and “comprising retrospective clinical response data indicating whether or not each patient in a plurality of patients is responsive to a treatment or therapy” are insignificant extra-solution activity of data gathering; Depending claims 62-72 do not remedy these deficiencies: Claims 62-65 further recite limitations pertaining to mental process abstract idea of a human observer visually perceiving relevant plotted data in the feature coordinate space in conjunction with visually perceiving the lines through the coordinate space marking linear boundaries or linear cutoffs. Claims 66, 69, and70 further recite limitations pertaining to recited math abstract ideas and insignificant extra-solution activity of data outputting additional elements. Claims 67 further recites limitations pertaining to recited math abstract ideas. Claim 68 further recites limitations pertaining to recited math abstract ideas and insignificant extra-solution activity of data gathering additional elements. As per claim(s) 73-82, arguments made in rejecting claim(s) 61-70 are analogous, respectively. Claims 73-82 further recite, “A system comprising: data processing hardware; and memory hardware in communication with the data processing hardware and storing instructions that when executed on the data processing hardware causes the data processing hardware to perform operations”, which are additional elements that area generically recited computer elements that do not add a meaningful limitation to the abstract idea because they amount to simply implementing the abstract idea on a computer and are mere instructions to implement an abstract idea on a computer, or merely uses a computer as a tool to perform an abstract idea - see MPEP 2106.05(f). Allowable Subject Matter Claims 61-70 and 73-82 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 101 set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: The closest prior art is US 20210098082 A1 (Udyavar). Limitations pertaining to “determining, from a plurality of possible classifications of CD8 localization, a classification of CD8 localization in the sample of the tumor by applying a patient response model to the polar coordinate transformation of the image analysis results that maps a value of the real inflammation score and a value of the tumor infiltration score in a feature space, the feature space comprising a plot having a first axis and a second axis and defining linear boundaries or linear cutoffs between the plurality of possible classifications of CD8 localization”, in conjunction with other limitations present in the independent claim(s), distinguish over the prior art. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Atiba Fitzpatrick whose telephone number is (571) 270-5255. The examiner can normally be reached on M-F 10:00am-6pm. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Andrew Bee can be reached on (571) 270-5183. The fax phone number for Atiba Fitzpatrick is (571) 270-6255. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Atiba Fitzpatrick /ATIBA O FITZPATRICK/ Primary Examiner, Art Unit 2677
Read full office action

Prosecution Timeline

Show 1 earlier event
Nov 13, 2025
Non-Final Rejection mailed — §101
Feb 11, 2026
Response Filed
Apr 22, 2026
Final Rejection mailed — §101
Jul 17, 2026
Examiner Interview Summary
Jul 17, 2026
Applicant Interview (Telephonic)
Jul 17, 2026
Request for Continued Examination
Jul 21, 2026
Response after Non-Final Action
Aug 12, 2026
Non-Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12749348
System and method for determining liveness using face rotation
2y 3m to grant Granted Sep 29, 2026
Patent 12743485
Systems and Methods for Enhancing Trainable Optical Character Recognition (OCR) Performance
5y 1m to grant Granted Sep 22, 2026
Patent 12743750
BLIND IMAGE DENOISING METHOD, ELECTRONIC DEVICE, AND STORAGE MEDIUM
2y 8m to grant Granted Sep 22, 2026
Patent 12743787
COMPONENT INSPECTION METHOD AND COMPONENT INSPECTION DEVICE
2y 4m to grant Granted Sep 22, 2026
Patent 12738023
Image Classification Device and Image Classification Method
2y 8m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
88%
Grant Probability
94%
With Interview (+6.0%)
2y 6m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 913 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month